methadone has been researched along with propranolol in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (62.96) | 18.7374 |
| 1990's | 1 (3.70) | 18.2507 |
| 2000's | 4 (14.81) | 29.6817 |
| 2010's | 5 (18.52) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, PR; Craik, DJ; Martin, JL | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Berkowitz, BA | 1 |
| Stickney, JL | 2 |
| Anggård, E; Eriksson, JH; Holmstrand, J; Jacob, RG | 1 |
| Wood, M | 1 |
| Cerri, C; Cocco, E; Rovati, L | 1 |
| Grosz, HJ | 1 |
| Gourley, DR | 1 |
| Contreras, E; Huidobro, F; Tamayo, L | 1 |
| Hollister, LE; Prusmack, JJ | 1 |
| Kersh, ES; Schwartz, LK | 1 |
| Krstíc, MK | 1 |
| Marshall, AS; Weinstock, M | 1 |
| Kehlet, H | 1 |
| Borowitz, JL; Maickel, RP; Ng, DS | 1 |
| Borowitz, JL; Maickel, RP; Shanbaky, NM | 1 |
| Boukef, MF; Duché, JC; Jolliet-Riant, P; Simon, N; Tillement, JP | 1 |
3 review(s) available for methadone and propranolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The relationship of pharmacokinetics to pharmacological activity: morphine, methadone and naloxone.
Topics: Absorption; Aging; Aspirin; Blood Proteins; Dose-Response Relationship, Drug; Drug Interactions; Female; Half-Life; Humans; Hydrogen-Ion Concentration; Kinetics; Male; Methadone; Morphine; Morphine Dependence; Naloxone; Propranolol; Protein Binding; Sex Factors; Substance-Related Disorders | 1976 |
Plasma drug binding: implications for anesthesiologists.
Topics: Age Factors; Alfentanil; Alprenolol; Anesthesia; Anesthetics; Blood Proteins; Bupivacaine; Burns; Cardiac Surgical Procedures; Chlorpromazine; Dipyridamole; Disopyramide; Etidocaine; Female; Fentanyl; Half-Life; Humans; Imipramine; Kidney Diseases; Lidocaine; Liver; Mathematics; Meperidine; Methadone; Myocardial Infarction; Orosomucoid; Prazosin; Pregnancy; Propranolol; Protein Binding; Quinidine; Serum Albumin; Sex Factors | 1986 |
3 trial(s) available for methadone and propranolol
| Article | Year |
|---|---|
Propranolol in the treatment of opiate dependence -- a controlled study.
Topics: Adolescent; Adult; Clinical Trials as Topic; Euphoria; Female; Heart Rate; Humans; Male; Methadone; Morphine; Morphine Dependence; Narcotic Antagonists; Placebos; Propranolol; Substance Withdrawal Syndrome; Substance-Related Disorders | 1975 |
Narcotic withdrawal symptoms in heroin users treated with propranolol.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Clinical Trials as Topic; Female; Heroin; Humans; Methadone; Nausea; Placebos; Propranolol; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors; Vomiting | 1972 |
Propranolol in withdrawal from opiates.
Topics: Adult; Chloral Hydrate; Drug Therapy, Combination; Heroin Dependence; Humans; Methadone; Narcotic Antagonists; Placebos; Propranolol; Substance Withdrawal Syndrome; Time Factors | 1974 |
21 other study(ies) available for methadone and propranolol
| Article | Year |
|---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Effect of autonomic blocking agents on chronotropic actions of 1-alpha-acetylmethadol.
Topics: Animals; Atropine; Autonomic Agents; Dogs; Drug Interactions; Female; Guinea Pigs; Heart Rate; In Vitro Techniques; Male; Methacholine Compounds; Methadone; Methadyl Acetate; Physostigmine; Propranolol | 1978 |
Cardiac effects of 1-alpha-acetylmethadol. IV. Mechanism of inotropic effects.
Topics: Animals; Calcium; Depression, Chemical; Dopamine; Guinea Pigs; In Vitro Techniques; Methadone; Methadyl Acetate; Myocardial Contraction; Propranolol; Stimulation, Chemical | 1978 |
Propranolol and clonidine in detoxification.
Topics: Clonidine; Humans; Lorazepam; Methadone; Opioid-Related Disorders; Propranolol; Psychomotor Agitation | 1988 |
Effects of opioid narcotic drugs on energy reserves of skeletal muscle. I. Glycogen.
Topics: Animals; Calcium; Carbon Radioisotopes; Diaphragm; Drug Tolerance; Energy Metabolism; Epinephrine; Glucose; Glycogen; Glycogen Synthase; In Vitro Techniques; Male; Meperidine; Methadone; Morphinans; Morphine; Muscles; Narcotics; Phosphoglucomutase; Phosphorylases; Propranolol; Rats; Time Factors | 1974 |
The influence of drugs affecting cyclic AMP levels on methadone induced potentiation of adrenaline effects.
Topics: Aminophylline; Animals; Cats; Cyclic AMP; Drug Interactions; Drug Synergism; Electric Stimulation; Epinephrine; Female; Fluorides; Guinea Pigs; Heart Atria; Imidazoles; In Vitro Techniques; Male; Methadone; Muscle Contraction; Papillary Muscles; Propranolol; Rabbits; Seminal Vesicles; Stimulation, Chemical; Uterus | 1972 |
Narcotic poisoning: an epidemic disease.
Topics: Diazepam; Glucose; Hospitalization; Humans; Hyperglycemia; Methadone; Myelitis, Transverse; Myoglobinuria; Naloxone; Narcotics; New York City; Pneumonia, Aspiration; Propranolol; Pulmonary Edema; Respiration; Substance Withdrawal Syndrome; Substance-Related Disorders; Tetanus Toxoid | 1973 |
The action of hordenine on the superior cervical ganglion of the cat.
Topics: Adrenal Glands; Adrenalectomy; Animals; Atropine; Cats; Cocaine; Dimethylamines; Dimethylphenylpiperazinium Iodide; Dose-Response Relationship, Drug; Drug Synergism; Electric Stimulation; Epinephrine; Female; Ganglia, Spinal; Hexamethonium Compounds; In Vitro Techniques; Male; Methadone; Morphine; Muscle Contraction; Nicotine; Nictitating Membrane; Phenethylamines; Propranolol; Receptors, Adrenergic; Receptors, Cholinergic; Time Factors | 1973 |
The influence of the sympathetic nervous system on the action of drugs on the lens.
Topics: Animals; Blepharoptosis; Body Temperature; Cataract; Chlorpromazine; Female; Guanethidine; Imipramine; Methadone; Mice; Phenoxybenzamine; Phentolamine; Propranolol; Reserpine; Sympathectomy; Sympathetic Nervous System | 1969 |
Should regional anesthesia and pharmacological agents such as beta blockers and opiates be utilized in modulating pain response?
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alfentanil; Analgesia; Analgesics; Anesthesia, Conduction; Animals; Burns; Cyclooxygenase Inhibitors; Fentanyl; Half-Life; Humans; Methadone; Models, Chemical; Morphine; Narcotics; Nerve Block; Pain; Pain Management; Propranolol | 1984 |
Subcellular distribution of weak acids and bases in adrenal medulla.
Topics: Acids; Adrenal Medulla; Alkalies; Animals; Binding, Competitive; Cattle; In Vitro Techniques; Kinetics; Methadone; Perfusion; Propranolol; Subcellular Fractions | 1982 |
Subcellular distribution of drugs in rat pancreas.
Topics: Animals; Decamethonium Compounds; Male; Methadone; Pancreas; Pharmaceutical Preparations; Propranolol; Rats; Subcellular Fractions; Trypsin | 1980 |
The genetic variant A of human alpha 1-acid glycoprotein limits the blood to brain transfer of drugs it binds.
Topics: Animals; Blood-Brain Barrier; Chlorpromazine; Disopyramide; Genetic Variation; Humans; Imipramine; Male; Methadone; Mifepristone; Orosomucoid; Pharmacokinetics; Propranolol; Protein Binding; Rats; Rats, Wistar | 1998 |